Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$15.26 - $28.61 $4.58 Million - $8.58 Million
-300,000 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$20.58 - $28.96 $1.03 Million - $1.45 Million
50,000 Added 20.0%
300,000 $6.5 Million
Q2 2020

Aug 14, 2020

SELL
$11.15 - $24.64 $278,750 - $616,000
-25,000 Reduced 9.09%
250,000 $5.89 Million
Q1 2020

May 15, 2020

BUY
$8.75 - $16.3 $2.41 Million - $4.48 Million
275,000 New
275,000 $3.24 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.76B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Alkeon Capital Management LLC Portfolio

Follow Alkeon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alkeon Capital Management LLC with notifications on news.